Haemonetics
195 hedge funds and large institutions have $2.18B invested in Haemonetics in 2013 Q2 according to their latest regulatory filings, with 195 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
102.87% more ownership
Funds ownership: 0% → 102.87% (+103%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $248K
Top Buyers
Top Sellers
HAE Hedge Fund Activity: Q2 2013 in Review
195 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2013, worth a combined $2.18B.
Buyers outnumbered sellers: 195 funds opened new HAE positions and 0 closed out — a net gain of 195 holders — while 0 added to existing stakes and 0 trimmed.
- 195 institutional investors held Haemonetics (HAE) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $2.18B of Haemonetics stock for Q2 2013.
- 195 funds opened new Haemonetics positions in Q2 2013 and 0 closed out, a net change of +195 holders.
Based on aggregated 13F filings for Q2 2013.